| Product NDC: | 54738-951 |
| Proprietary Name: | ribavirin |
| Non Proprietary Name: | ribavirin |
| Active Ingredient(s): | 400 mg/1 & nbsp; ribavirin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 54738-951 |
| Labeler Name: | Richmond Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077456 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080601 |
| Package NDC: | 54738-951-56 |
| Package Description: | 56 TABLET, FILM COATED in 1 BOTTLE (54738-951-56) |
| NDC Code | 54738-951-56 |
| Proprietary Name | ribavirin |
| Package Description | 56 TABLET, FILM COATED in 1 BOTTLE (54738-951-56) |
| Product NDC | 54738-951 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ribavirin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20080601 |
| Marketing Category Name | ANDA |
| Labeler Name | Richmond Pharmaceuticals, Inc. |
| Substance Name | RIBAVIRIN |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |